Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3020 |
|
| Actual shortage: | 234 (8%) | |
| Anticipated shortage: | 20 (1%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2757 (91%) | |
Discontinuation Reports |
356 |
|
| To be discontinued: | 22 (6%) | |
| Discontinued: | 334 (94%) | |
| Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
28 (10%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-QUETIAPINE | 100MG | TABLET | Resolved | 2021-04-05 | 2021-05-31 | 136811 |
| APO-TETRABENAZINE | 25MG | TABLET | Resolved | 2021-04-05 | 2021-05-03 | 136814 |
| APO-VARDENAFIL | 20MG | TABLET | Resolved | 2021-04-05 | 2021-10-25 | 136817 |
| APO-CLOPIDOGREL | 300MG | TABLET | Resolved | 2021-04-09 | 2021-04-19 | 137238 |
| APO-EMTRICITABINE-TENOFOVIR | 300MG 200MG | TABLET | Resolved | 2021-04-09 | 2021-06-07 | 137241 |
| APO-ESCITALOPRAM | 20MG | TABLET | Resolved | 2021-04-09 | 2021-05-17 | 137244 |
| APO-IBUPROFEN | 400MG | TABLET | Resolved | 2021-04-09 | 2021-05-01 | 137250 |
| APO-MELOXICAM | 1.5G | SUSPENSION | Resolved | 2021-04-09 | 2021-05-17 | 137257 |
| APO-METHYLPHENIDATE ER | 36MG | TABLET (EXTENDED-RELEASE) | Resolved | 2021-04-09 | 2021-05-01 | 137261 |
| APO-METHYLPHENIDATE ER | 36MG | TABLET (EXTENDED-RELEASE) | Resolved | 2021-04-09 | 2021-05-01 | 137264 |
| APO-PRAVASTATIN | 40MG | TABLET | Resolved | 2021-04-09 | 2021-04-19 | 137267 |
| APO-RAMIPRIL | 10MG | CAPSULE | Resolved | 2021-04-09 | 2021-05-03 | 137272 |
| APO-IBUPROFEN TAB 600MG | 600MG | TABLET | Resolved | 2021-04-16 | 2021-05-01 | 137575 |
| APO-IMATINIB | 400MG | TABLET | Resolved | 2021-04-16 | 2021-05-17 | 137578 |
| APO-METHYLPHENIDATE ER | 27MG | TABLET (EXTENDED-RELEASE) | Resolved | 2021-04-16 | 2021-09-27 | 137581 |
| APO-MIDODRINE | 5MG | TABLET | Resolved | 2021-04-16 | 2021-04-26 | 137584 |
| APO-PAROXETINE | 20MG | TABLET | Resolved | 2021-04-16 | 2021-04-26 | 137592 |
| APO-PREGABALIN | 225MG | CAPSULE | Resolved | 2021-04-16 | 2021-04-26 | 137595 |
| APO-AMLODIPINE-ATORVASTATIN | 5MG 40MG | TABLET | Resolved | 2021-04-23 | 2021-05-26 | 137956 |
| APO-KETOROLAC | 10MG | TABLET | Resolved | 2021-04-23 | 2021-05-17 | 137959 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-CELECOXIB | 100MG | CAPSULE | To be discontinued | 2018-09-07 | 2018-12-11 | 60363 |
| APO-CILAZAPRIL | 1MG | TABLET | To be discontinued | 2018-09-07 | 2018-12-28 | 60373 |
| APO-CLINDAMYCIN | 150MG | CAPSULE | To be discontinued | 2018-09-07 | 2018-12-28 | 60396 |
| APO-DICLO RAPIDE 50 MG TABLETS | 50MG | TABLET | To be discontinued | 2018-09-07 | 2018-11-02 | 60423 |
| APO-METOPROLOL | 25MG | TABLET | To be discontinued | 2018-09-07 | 2021-06-03 | 60628 |
| APO-OXAZEPAM | 15MG | TABLET | To be discontinued | 2018-09-08 | 2018-09-08 | 60678 |
| APO-RANITIDINE TABLET 300MG | 300MG | TABLET | To be discontinued | 2018-09-08 | 2018-09-08 | 60732 |
| APO-RILUZOLE | 50MG | TABLET | To be discontinued | 2018-09-08 | 2018-09-08 | 60744 |
| APO-RISPERIDONE | 1MG | SOLUTION | To be discontinued | 2018-09-08 | 2018-09-08 | 60753 |
| APO-ALENDRONATE | 10MG | TABLET | To be discontinued | 2019-01-03 | 2019-12-20 | 71026 |
| APO-AMITRIPTYLINE | 50MG | TABLET | To be discontinued | 2019-01-04 | 2021-06-05 | 71354 |
| APO-RISPERIDONE | 1MG | SOLUTION | To be discontinued | 2019-03-11 | 2019-03-11 | 78260 |
| TIGECYCLINE | 50MG | POWDER FOR SOLUTION | To be discontinued | 2019-06-21 | 2019-06-21 | 87218 |
| APO-CARVEDILOL | 12.5MG | TABLET | To be discontinued | 2024-01-26 | 2024-04-01 | 217493 |
| APO-CARVEDILOL | 3.125MG | TABLET | To be discontinued | 2024-01-26 | 2024-01-26 | 217496 |
| APO-CARVEDILOL | 6.25MG | TABLET | To be discontinued | 2024-01-26 | 2024-01-26 | 217499 |